112 related articles for article (PubMed ID: 20187356)
1. [The Tunisian cognitive battery for patients with schizophrenia].
Ben Azouz O; Dellagi L; Kebir O; Johnson I; Amado I; Tabbane K
Tunis Med; 2009 Oct; 87(10):674-9. PubMed ID: 20187356
[TBL] [Abstract][Full Text] [Related]
2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
3. [Tunisian adaptation of Hopkins Verbal Learning Test , Form 1].
Dellagi L; Ben Azouz O; Johnson I; Kebir O; Amado I; Tabbane K
Tunis Med; 2009 Oct; 87(10):670-3. PubMed ID: 20187355
[TBL] [Abstract][Full Text] [Related]
4. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
5. [Neurocognitive subtypes of schizophrenia according to performance at verbal fluency tasks].
Robert PH; Thauby S; Migneco V; Chaix I; Caci H; Benoit M; Pringuey D; Darcourt G
Encephale; 1996; 22(6):435-42. PubMed ID: 10901836
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in neuropsychological functioning among schizophrenia patients.
Bozikas VP; Kosmidis MH; Peltekis A; Giannakou M; Nimatoudis I; Karavatos A; Fokas K; Garyfallos G
Aust N Z J Psychiatry; 2010 Apr; 44(4):333-41. PubMed ID: 20050721
[TBL] [Abstract][Full Text] [Related]
7. [Measuring the cognitive deficit associated with schizophrenia: presentation of the MATRICS neuropsychological test battery].
Sarolta K; Pál C; István B
Neuropsychopharmacol Hung; 2007 Oct; 9(3):143-50. PubMed ID: 18399033
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the MATRICS and IntegNeuro cognitive assessment batteries.
Silverstein SM; Jaeger J; Donovan-Lepore AM; Wilkniss SM; Savitz A; Malinovsky I; Hawthorne D; Raines S; Carson S; Marcello S; Zukin SR; Furlong S; Dent G
J Clin Exp Neuropsychol; 2010 Nov; 32(9):937-52. PubMed ID: 20455131
[TBL] [Abstract][Full Text] [Related]
9. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
10. Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia.
Stip E; Caron J; Renaud S; Pampoulova T; Lecomte Y
Compr Psychiatry; 2003; 44(4):331-40. PubMed ID: 12923712
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between cognitive defects and the course of schizophrenia. Initial study of a rehabilitation programme participants].
Hanuszkiewicz I; Cechnicki A; Kalisz A
Psychiatr Pol; 2007; 41(4):539-50. PubMed ID: 18046984
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment but preservation of sexual dimorphism in cognitive abilities in chronic schizophrenia.
Halari R; Mehrotra R; Sharma T; Ng V; Kumari V
Psychiatry Res; 2006 Feb; 141(2):129-39. PubMed ID: 16427141
[TBL] [Abstract][Full Text] [Related]
14. Use of Barcelona Test for cognitive assessment of patients with schizophrenia.
Gil D; Bengochea R; Arrieta M; Lastra I; Sánchez R; Alvarez A; Diego M; Prat R
Actas Esp Psiquiatr; 2008; 36(6):337-44. PubMed ID: 18781409
[TBL] [Abstract][Full Text] [Related]
15. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
Nuechterlein KH; Green MF; Kern RS; Baade LE; Barch DM; Cohen JD; Essock S; Fenton WS; Frese FJ; Gold JM; Goldberg T; Heaton RK; Keefe RS; Kraemer H; Mesholam-Gately R; Seidman LJ; Stover E; Weinberger DR; Young AS; Zalcman S; Marder SR
Am J Psychiatry; 2008 Feb; 165(2):203-13. PubMed ID: 18172019
[TBL] [Abstract][Full Text] [Related]
16. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
[TBL] [Abstract][Full Text] [Related]
17. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria.
Green MF; Nuechterlein KH; Gold JM; Barch DM; Cohen J; Essock S; Fenton WS; Frese F; Goldberg TE; Heaton RK; Keefe RS; Kern RS; Kraemer H; Stover E; Weinberger DR; Zalcman S; Marder SR
Biol Psychiatry; 2004 Sep; 56(5):301-7. PubMed ID: 15336511
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological performance in first-episode adolescents with schizophrenia: a comparison with first-episode adults and adolescent control subjects.
White T; Ho BC; Ward J; O'Leary D; Andreasen NC
Biol Psychiatry; 2006 Sep; 60(5):463-71. PubMed ID: 16566898
[TBL] [Abstract][Full Text] [Related]
19. Cognitive functioning in siblings discordant for schizophrenia.
Hughes C; Kumari V; Das M; Zachariah E; Ettinger U; Sumich A; Sharma T
Acta Psychiatr Scand; 2005 Mar; 111(3):185-92. PubMed ID: 15701102
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychological impairment in deficit vs. non-deficit schizophrenia.
Cascella NG; Testa SM; Meyer SM; Rao VA; Diaz-Asper CM; Pearlson GD; Schretlen DJ
J Psychiatr Res; 2008 Sep; 42(11):930-7. PubMed ID: 18021807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
